Literature DB >> 19955725

From electric acoustic stimulation to improved sound coding in cochlear implants.

Peter Nopp, Marek Polak.   

Abstract

Research into electric acoustic stimulation (EAS) indicates that performance improves when acoustic stimulation is added to electric stimulation in subjects with residual low-frequency acoustic hearing. Research further indicates that information from the voice fundamental frequency (F(0)) region accounts for the majority of the added speech perception benefit with EAS. This implies that improved frequency coding in the low frequencies could hold great potential for improving performance with cochlear implants (CIs). Results with new speech coding strategies such as fine structure processing indeed indicate that with improved low-frequency coding, at least some of the benefits of EAS can be translated to regular CI users. Copyright 2010 S. Karger AG, Basel.

Mesh:

Year:  2009        PMID: 19955725     DOI: 10.1159/000262600

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  4 in total

Review 1.  A systematic review of electric-acoustic stimulation: device fitting ranges, outcomes, and clinical fitting practices.

Authors:  Paola V Incerti; Teresa Y C Ching; Robert Cowan
Journal:  Trends Amplif       Date:  2013-03

2.  Fine structure processing improves telephone speech perception in cochlear implant users.

Authors:  Javier Galindo; Luis Lassaletta; Rosa Pérez Mora; Alejandro Castro; Marta Bastarrica; Javier Gavilán
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-06       Impact factor: 2.503

Review 3.  The effectiveness of sound-processing strategies on tonal language cochlear implant users: A systematic review.

Authors:  Haihong Liu; Xiaoxia Peng; Yawen Zhao; Xin Ni
Journal:  Pediatr Investig       Date:  2017-12-27

Review 4.  Electric and Acoustic Stimulation in Cochlear Implant Recipients with Hearing Preservation.

Authors:  Christopher Welch; Margaret T Dillon; Harold C Pillsbury
Journal:  Semin Hear       Date:  2018-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.